Clinical trial
Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage…
NCT00003387 · Alliance for Clinical Trials in Oncology, Other · Completed
Key facts
| NCT number | NCT00003387 |
|---|---|
| Title | Carboplatin, Paclitaxel, and Radiation Therapy in Treating Patients With Stage III Non-small Cell Lung Cancer That Cannot Be Removed During Surgery |
| Official title | Concurrent Carboplatin, Paclitaxel, and Radiation Therapy Versus Induction Carboplatin and Paclitaxel Followed by Concurrent Carboplatin, Paclitaxel and Radiation Therapy for Patients With Unresectable Stage III Non-Small Cell Lung Cancer: A Phase III Trial |
| Lead sponsor | Alliance for Clinical Trials in Oncology, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lung Cancer |
| Intervention type | Drug, Radiation |
| Interventions | carboplatin, chemotherapy, paclitaxel, radiation therapy |
| Enrollment | 366 |
| Start date | Jul 1, 1998 |
| Primary completion | May 1, 2007 |
| Completion | Apr 1, 2009 |
| First posted | Nov 26, 2003 |
| Last update posted | Jul 20, 2016 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: